E-cadherin expression and prognosis of oral cancer: A meta-analysis

Tumor Biology

Volumn 35, Issue 6, 2014, Pages 5533-5537

  Luo, Sheng Lei ^a,b   Xie, Yong Gang ^c   Li, Zhen ^d   Ma, Jia Hai ^c   Xu, Xin ^a  

^a People's Republic of China   (China)

^b THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

^c QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

^d SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

E cadherin; Oral cancer; Prognosis

Indexed keywords

UVOMORULIN;

ARTICLE; ASIAN; CANCER PATIENT; CANCER PROGNOSIS; CLINICAL ASSESSMENT; FOLLOW UP; HUMAN; INFORMATION RETRIEVAL; META ANALYSIS; MOUTH SQUAMOUS CELL CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY;

CADHERINS; CARCINOMA, SQUAMOUS CELL; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; IMMUNOHISTOCHEMISTRY; MOUTH NEOPLASMS; PROGNOSIS; PUBLICATION BIAS;

EID: 84904727382     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-1728-0     Document Type: Article

References (24)

1. Poljak M, Rogovskaya SI, Kesić V, et al. Recommendations for cervical cancer prevention in central and eastern Europe and central Asia. Vaccine. 2013;31 Suppl 7:H80-2.
2. Krishna Rao SV, Mejia G, Roberts-Thomson K, Logan R. Epidemiology of oral cancer in Asia in the past decade- an update (2000-2012). Asian Pac J Cancer Prev. 2013;14:5567-77.
3. Foulkes M. Oral cancer: risk factors, treatment and nursing care. Nurs Stand. 2013;28(8):49-57.
4. Joshi A, Patil VM, Noronha V, et al. Is there a role of induction chemotherapy followed by resection in T4b oral cavity cancers? Indian J Cancer. 2013;50:349-55.
5. Ulla M, Gentile E, Yeyati EL, et al. Pneumo-CT assessing response to neoadjuvant therapy in esophageal cancer: imaging-pathological correlation. World J Gastrointest Oncol. 2013;5:222-9.
6. da Silva SD, Alaoui-Jamali MA, Soares FA, et al. TWIST1 is a molecular marker for a poor prognosis in oral cancer and represents a potential therapeutic target. Cancer. 2013. doi:10.1002/cncr.28404.
7. Inui T, Chano T, Takikita-Suzuki M, et al. Association of p62/SQSTM1 excess and oral carcinogenesis. PLoS One. 2013;8:e74398.
8. Lausoontornsiri W, Chindavijak S, Sangariyavanich E, Sakapiboonnan A. Apoptosis inhibitor showed a significant prognostic marker of relapsed oral cavity cancer after the curative resection surgery. J Med Assoc Thai. 2013;96:917-23.
9. Søland TM, Brusevold IJ. Prognostic molecular markers in cancer - quo vadis? Histopathology. 2013;63:297-308.
10. Faleiro-Rodrigues C, Lopes C. E-cadherin, CD44 and CD44v6 in squamous intraepithelial lesions and invasive carcinomas of the uterine cervix: an immunohistochemical study. Pathobiology. 2004;71:329-36. (Pubitemid 40082314)
11. Zhou XD. Recurrence and metastasis of hepatocellular carcinoma: progress and prospects. Hepatobiliary Pancreat Dis Int. 2002;1:35-41.
12. Tseng RC, Lee SH, Hsu HS, et al. SLIT2 attenuation during lung cancer progression deregulates beta-catenin and E-cadherin and associates with poor prognosis. Cancer Res. 2010;70:543-51.
13. Pannone G, Santoro A, Feola A, et al. The role of E-cadherin down-regulation in oral cancer: Cdh1 gene expression and epigenetic blockage. Curr Cancer Drug Targets. 2013. doi:10.2174/1568009613666131126115012.
14. Fan CC, Wang TY, Cheng YA, et al. Expression of E-cadherin, Twist, and p53 and their prognostic value in patientswith oral squamous cell carcinoma. 2. J Cancer Res Clin Oncol. 2013;139:1735-44.
15. Zhao D, Tang XF, Yang K, Liu JY, Ma XR. Over-expression of integrin-linked kinase correlates with aberrant expression of Snail, E-cadherin and N-cadherin in oral squamous cell carcinoma: implications in tumor progression and metastasis. Clin Exp Metastasis. 2012;29:957-69.
16. Rosado P, Lequerica-Fernández P, Fernández S, et al. E-cadherin and β-catenin expression in well-differentiated and moderately-differentiated oral squamous cell carcinoma: relations with clinical variables. Br J Oral Maxillofac Surg. 2013;51:149-56.
17. Wang C, Liu X, Chen Z, et al. Polycomb group protein EZH2-mediated E-cadherin repression promotes metastasis of oral tongue squamous cell carcinoma. Mol Carcinog. 2013;52:229-36.
18. Wang C, Huang H, Huang Z, et al. Tumor budding correlates with poor prognosis and epithelial-mesenchymal transition in tongue squamous cell carcinoma. J Oral Pathol Med. 2011;40:545-51.
19. Pyo SW, Hashimoto M, Kim YS, et al. Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome. J Craniomaxillofac Surg. 2007;35:1-9.
20. Foschini MP, Cocchi R, Morandi L, et al. E-cadherin loss and Delta Np73L expression in oral squamous cell carcinomas showing aggressive behavior. Head Neck. 2008;30:1475-82.
21. Diniz-Freitas M, García-Caballero T, Antúnez-López J, Gándara-Rey JM, García-García A. Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinoma. Oral Oncol. 2006;42:190-200. (Pubitemid 43106884)
22. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. 2009;119:1420-8.
23. Kang Y, Massague J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell. 2004;118:277-9. (Pubitemid 39061108)
24. Malaguti M, Nistor PA, Blin G, Pegg A, Zhou X, Lowell S. Bone morphogenic protein signalling suppresses differentiation of pluripotent cells by maintaining expression of E-Cadherin. Elife. 2013;2:e01197.